Drug profile

The FDA adverse-event record for Parvovirus Vaccine

25 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Parvovirus Vaccine. See the species affected, top reactions, and outcomes below.

25
adverse-event reports
20.0%
death-coded share
Dog
most-reported species
6
Other abnormal test result NOS - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
25
Total Reports
5
Deaths Reported
20.0%
Death Rate

Active Ingredients

Parvovirus Vaccine

Administration Routes

UnknownSubcutaneousOphthalmic

Species Affected

Dog 25

Most Affected Breeds

Retriever - Labrador 3
Chihuahua 3
Retriever - Golden 2
Boxer (German Boxer) 1
Lhasa Apso 1
Collie - Border 1
Mastiff 1
Shih Tzu 1
Schnauzer - Miniature 1
Portuguese Water Dog 1

Most Reported Reactions

Other abnormal test result NOS 6
Vomiting 5
Behavioural disorder NOS 4
Elevated alanine aminotransferase (ALT) 4
Lethargy (see also Central nervous system depression in 'Neurological') 4
Elevated serum alkaline phosphatase (SAP) 3
Diarrhoea 3
Bloody diarrhoea 3
Death by euthanasia 3
Cough 2
Weakness 2
Abnormal radiograph finding 2

Outcome Breakdown

Ongoing
9 (36.0%)
Recovered/Normal
7 (28.0%)
Outcome Unknown
4 (16.0%)
Euthanized
4 (16.0%)
Died
1 (4.0%)

Parvovirus Vaccine Adverse Event Insights

25 reports name Parvovirus Vaccine; 5 recorded a death outcome (20.0% of reported events, not a population-level mortality rate). Active ingredient: Parvovirus Vaccine. Administration routes: Unknown, Subcutaneous, Ophthalmic.

By species: Dog (25 reports). By breed: Retriever - Labrador (3), Chihuahua (3), Retriever - Golden (2).

Leading clinical signs: Other abnormal test result NOS (6), Vomiting (5), Behavioural disorder NOS (4), Elevated alanine aminotransferase (ALT) (4). Outcome, 25 coded reports: Ongoing leads at 36.0%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.